Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Recent insights into the mechanism of action of glatiramer acetate.
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
The use of hematopoietic stem cells in autoimmune diseases.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Flupirtine in pain management: pharmacological properties and clinical use.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Multiple sclerosis: association with HL-A3.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.

Pages